Completed NA INTERVENTIONAL NCT00222222

Mediators of Inflammation, Prognostic Markers and Genetic Polymorphisms in Patients With Sepsis

Sponsor: Universitätsmedizin Mannheim

Conditions Sepsis

Updated 6 times since 2017 Last updated: Feb 14, 2012 Started: Mar 31, 2003 Primary completion: Dec 31, 2011 Completion: Dec 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Sepsis and is currently completed. Universitätsmedizin Mannheim leads this study, which shows 6 recorded versions since 2003 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Mar 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Universitätsmedizin Mannheim

Data source: Universitätsmedizin Mannheim

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• University Hospital Mannheim, Germany